Radicle Science's ACES (Advancing CBD Education & Science) study was an IRB approved 4 week, 14 arm, open label randomized clinical trial of 13 CBD products plus a waitlist control group, involving nearly 3,000 diverse participants, assessing validated outcome measures of well being, quality of life, pain, sleep, and anxiety, and tracking usage behavior and side effects.
1. Discuss current knowledge of the therapeutic potential of CBD.
2. Evaluate the current regulatory landscape for CBD in the U.S. and the mislabeling of products.
3. Assess lessons from the ACES study regarding the product attributes most associated with improvements.